Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 13 studies | 26% ± 7% | |
| conventional dendritic cell | 8 studies | 28% ± 7% | |
| non-classical monocyte | 8 studies | 21% ± 4% | |
| classical monocyte | 7 studies | 19% ± 4% | |
| myeloid cell | 6 studies | 27% ± 6% | |
| fibroblast | 6 studies | 20% ± 4% | |
| dendritic cell | 6 studies | 25% ± 7% | |
| platelet | 5 studies | 21% ± 7% | |
| monocyte | 5 studies | 25% ± 6% | |
| epithelial cell | 4 studies | 36% ± 23% | |
| B cell | 4 studies | 17% ± 2% | |
| smooth muscle cell | 4 studies | 21% ± 3% | |
| pericyte | 4 studies | 23% ± 5% | |
| connective tissue cell | 3 studies | 18% ± 2% | |
| plasma cell | 3 studies | 33% ± 6% | |
| leukocyte | 3 studies | 20% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 1732.95 | 258 / 258 | 100% | 20.30 | 230 / 230 |
| uterus | 100% | 897.79 | 170 / 170 | 100% | 19.07 | 459 / 459 |
| skin | 100% | 858.31 | 1808 / 1809 | 100% | 22.59 | 472 / 472 |
| breast | 100% | 1129.43 | 459 / 459 | 100% | 30.98 | 1117 / 1118 |
| kidney | 100% | 1023.07 | 89 / 89 | 100% | 14.66 | 900 / 901 |
| esophagus | 100% | 657.34 | 1443 / 1445 | 100% | 15.27 | 183 / 183 |
| lung | 100% | 1708.27 | 578 / 578 | 100% | 19.08 | 1153 / 1155 |
| bladder | 100% | 764.71 | 21 / 21 | 100% | 19.39 | 503 / 504 |
| stomach | 100% | 675.88 | 358 / 359 | 100% | 17.61 | 286 / 286 |
| intestine | 100% | 854.23 | 966 / 966 | 99% | 18.14 | 524 / 527 |
| ovary | 100% | 873.89 | 180 / 180 | 99% | 11.12 | 427 / 430 |
| thymus | 100% | 779.32 | 651 / 653 | 99% | 8.30 | 600 / 605 |
| prostate | 100% | 665.70 | 244 / 245 | 99% | 9.20 | 498 / 502 |
| brain | 97% | 464.87 | 2556 / 2642 | 99% | 9.71 | 701 / 705 |
| pancreas | 91% | 330.42 | 299 / 328 | 99% | 12.18 | 176 / 178 |
| liver | 93% | 560.70 | 210 / 226 | 97% | 11.38 | 393 / 406 |
| adipose | 100% | 1177.13 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 15.91 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 30.29 | 29 / 29 |
| spleen | 100% | 1364.48 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 18.26 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.48 | 1 / 1 |
| peripheral blood | 100% | 1999.58 | 928 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 753.85 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| heart | 96% | 555.15 | 828 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 426.80 | 768 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051001 | Biological process | negative regulation of nitric-oxide synthase activity |
| GO_0016139 | Biological process | glycoside catabolic process |
| GO_0045019 | Biological process | negative regulation of nitric oxide biosynthetic process |
| GO_0046479 | Biological process | glycosphingolipid catabolic process |
| GO_0046477 | Biological process | glycosylceramide catabolic process |
| GO_0009311 | Biological process | oligosaccharide metabolic process |
| GO_0035578 | Cellular component | azurophil granule lumen |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005764 | Cellular component | lysosome |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0043202 | Cellular component | lysosomal lumen |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0004557 | Molecular function | alpha-galactosidase activity |
| GO_0016787 | Molecular function | hydrolase activity |
| GO_0003824 | Molecular function | catalytic activity |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0016936 | Molecular function | galactoside binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GLA |
| Protein name | Alpha-galactosidase (EC 3.2.1.-) Galactosidase, alpha Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Galactosylgalactosylglucosylceramidase GLA) (Melibiase) (Agalsidase) |
| Synonyms | hCG_20401 |
| Description | FUNCTION: Catalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome. . |
| Accessions | ENST00000218516.4 A0A6Q8PFA9 A0A669KB83 P06280 ENST00000675592.1 A0A6Q8PHD1 A0A3B3IUC4 A0A3B3IRU3 ENST00000493905.6 A0AA34QW02 ENST00000480513.6 A0A0S3Q2A7 A0A6Q8PHM8 A0A6Q8PGG0 V9GYN5 ENST00000486121.7 ENST00000674127.2 ENST00000710365.1 Q53Y83 ENST00000676156.1 ENST00000676372.1 ENST00000674634.2 ENST00000675799.1 ENST00000649178.1 |